Sökning: WFRF:(Latini Roberto) >
Prognostic Value of...
Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock : Data From the Albumin Italian Outcome Sepsis Study
-
- Rosjo, Helge (författare)
- Akershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, Norway
-
- Masson, Serge (författare)
- IRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy
-
- Caironi, Pietro (författare)
- Azienda Osped Univ S Luigi Gonzaga, Dept Anesthesia & Crit Care, Orbassano, Italy;Univ Torino, Dipartimento Oncol, Turin, Italy
-
visa fler...
-
- Stridsberg, Mats (författare)
- Uppsala universitet,Biokemisk endokrinologi
-
- Magnoli, Michela (författare)
- IRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy
-
- Christensen, Geir (författare)
- Inst Expt Med Res, Ulleval, Norway;Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, Norway
-
- Moise, Gabriella (författare)
- Osped Citta Sesto San Giovanni, Dept Anesthesia & Crit Care, Sesto San Giovanni, Italy
-
- Urbano, Maria Cristina (författare)
- Osped Misericordia, Grosseto, Italy
-
- Gattinoni, Luciano (författare)
- Univ Gottingen, Dept Anesthesiol Emergency & Intens Care Med, Gottingen, Germany
-
- Pesenti, Antonio (författare)
- Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Anestesia, Milan, Italy;Univ Milan, Dipartimento Fisiopatol Med Chirurg & Trapianti, Milan, Italy
-
- Latini, Roberto (författare)
- IRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy
-
- Omland, Torbjorn (författare)
- Akershus Univ Hosp, Div Med, Sykehusveien 25, N-1478 Lorenskog, Norway;Univ Oslo, Inst Clin Med, Ctr Heart Failure Res, Oslo, Norway
-
visa färre...
-
(creator_code:org_t)
- LIPPINCOTT WILLIAMS & WILKINS, 2018
- 2018
- Engelska.
-
Ingår i: Critical Care Medicine. - : LIPPINCOTT WILLIAMS & WILKINS. - 0090-3493 .- 1530-0293. ; 46:5, s. E404-E410
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objectives: Secretoneurin directly influences cardiomyocyte calcium handling, and circulating secretoneurin levels seem to improve risk prediction in patients with myocardial dysfunction by integrating information on systemic stress, myocardial function, and renal function. Accordingly, in this study, we hypothesized that secretoneurin would improve risk prediction in patients with sepsis and especially in patients with septic shock as these patients are more hemodynamically unstable. Design: Multicenter, interventional randomized clinical trial. Setting: Multicenter, pragmatic, open-label, randomized, prospective clinical trial testing fluid administration with either 20% human albumin and crystalloids or crystalloid solutions alone in patients with severe sepsis or septic shock (The Albumin Italian Outcome Sepsis). Patients or Subjects: In total, 540 patients with septic shock and 418 patients with severe sepsis. Interventions: Either 20% human albumin and crystalloids or crystalloid solutions alone. Measurements and Main Results: We measured secretoneurin on days 1, 2, and 7 after randomization and compared the prognostic value of secretoneurin for ICU and 90-day mortality with established risk indices and cardiac biomarkers in septic shock and severe sepsis. High secretoneurin levels on day 1 were associated with age and serum concentrations of lactate, bilirubin, creatinine, and N-terminal pro-B-type natriuretic peptide. Adjusting for established risk factors and cardiovascular biomarkers, secretoneurin levels on day 1 were associated with ICU (odds ratio, 2.27 [95% CI, 1.05-4.93]; p = 0.04) and 90-day mortality (2.04 [1.02-4.10]; p = 0.04) in patients with septic shock, but not severe sepsis without shock. Secretoneurin levels on day 2 were also associated with ICU (3.11 [1.34-7.20]; p = 0.008) and 90-day mortality (2.69 [1.26-5.78]; p = 0.01) in multivariate regression analyses and improved reclassification in patients with septic shock, as assessed by the net reclassification index. Randomized albumin administration did not influence the associations between secretoneurin and outcomes. Conclusions: Secretoneurin provides early and potent prognostic information in septic patients with cardiovascular instability.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Anestesi och intensivvård (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Anesthesiology and Intensive Care (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Allmänmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- General Practice (hsv//eng)
Nyckelord
- biomarkers
- secretoneurin
- sepsis
- septic shock
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Rosjo, Helge
-
Masson, Serge
-
Caironi, Pietro
-
Stridsberg, Mats
-
Magnoli, Michela
-
Christensen, Gei ...
-
visa fler...
-
Moise, Gabriella
-
Urbano, Maria Cr ...
-
Gattinoni, Lucia ...
-
Pesenti, Antonio
-
Latini, Roberto
-
Omland, Torbjorn
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Anestesi och int ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Allmänmedicin
- Artiklar i publikationen
-
Critical Care Me ...
- Av lärosätet
-
Uppsala universitet